Alfred Siegfried

PHD Doctor of Philosophy,  Charité - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Legal Support Scientific Writing Hospital-Pharmacy-Insurance Case Consulting

Areas Of Interest

Fenretinide, 13 cis Isomer Intervertebral Disk Displacements Spearmint Allergic Alveolitides, Extrinsic Endothelial Cell Craniomandibular Disorders Bacteroidaceae Infections Deafness, Transitory Bias, Selection Myeloid Stem Cells Acetaldehyde Dehydrogenase Inhibitors Classical Dengue E ewingii Infections alpha Methyltyrosine Hydrochloride Erythema Multiforme Suppressor of Cytokine Signaling Protein 3 Cyamopsis tetragonolobas Granulosa Cell, Cumulus Scintigraphies, Gated Blood-Pool Cycles, Cell HB420 Amido-beta-Lactam Hydrolase, Cephalosporin Stress, Physiological Disease, Rheumatic Heart Human Coprophagies Proto-Oncogene Proteins c-jun Receptor, PTHLP Cerebellar Ataxia, Late Onset Leukemia, Lymphoblastic, Acute, T Cell Cotazym-S p-Chloromercuribenzoic Acid Equid Herpesvirus 2 Myosin Type II

Professional Narrative

Dr. Alfred Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Executive Director, Harvard Med 2002
Executive Director, Mayo Clinic 1989

Education

Bachelor of science in nursing, Baylor College 1991
Doctor of osteopathic medicine, Yale School of Medicine 2009

Referees

Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02